Survivin, a potential early predictor of tumor progression in the oral mucosa

Journal of Dental Research

Volumn 82, Issue 11, 2003, Pages 923-928

  Lo Muzio, L ^a,f   Pannone, G ^b   Leonardi, R ^c   Staibano, S ^b   Mignogna, M D ^b   De Rosa, G ^b   Kudo, Y ^d   Takata, T ^d   Altieri, D C ^e  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c UNIVERSITY OF CATANIA   (Italy)

^d HIROSHIMA UNIVERSITY   (Japan)

^e UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^f NONE   (Italy)

Author keywords

Apoptosis; IAP; Oral squamous cell carcinoma; Precancerous lesion; Survivin

Indexed keywords

BIRC5 PROTEIN, HUMAN; MICROTUBULE ASSOCIATED PROTEIN; TUMOR ANTIGEN; TUMOR MARKER; TUMOR PROTEIN;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; BIOSYNTHESIS; CELL TRANSFORMATION; EARLY DIAGNOSIS; ENZYME IMMUNOASSAY; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; MOUTH MUCOSA; MOUTH TUMOR; PRECANCER; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTIGENS, NEOPLASM; CARCINOMA, SQUAMOUS CELL; CELL TRANSFORMATION, NEOPLASTIC; EARLY DIAGNOSIS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; MOUTH MUCOSA; MOUTH NEOPLASMS; NEOPLASM PROTEINS; PRECANCEROUS CONDITIONS; TUMOR MARKERS, BIOLOGICAL;

EID: 0642374091     PISSN: 00220345     EISSN: None     Source Type: Journal    
DOI: 10.1177/154405910308201115     Document Type: Article

References (30)

1. Al-Rajhi N, Khafaga Y, El-Husseiny J, Saleem M, Mourad W, Al-Otieschan A, et al. (2000). Early stage carcinoma of oral tongue: prognostic factors for local control and survival. Oral Oncol 36:508-514.
2. Altieri DC (2001). The molecular basis and potential role of survivin in cancer diagnosis and therapy. Trends Mol Med 7:542-547.
3. Ambrosini G, Adida C, Altieri DC (1997). A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 3:917-921.
4. Chiodino C, Cesinaro AM, Ottani D, Fantini F, Giannetti A, Trentini GP, et al. (1999). Communication: expression of the novel inhibitor of apoptosis survivin in normal and neoplastic skin. J Invest Dermatol 113:415-418.
5. Choi HR, Tucker SA, Huang Z, Gillemvater AM, Luna MA, Batsakis JG, et al. (2003). Differential expressions of cyclin-dependent kinase inhibitors (p27 and p21) and their relation to p53 and Ki-67 in oral squamous tumorigenesis. Int J Oncol 22:409-414.
6. Deveraux QL, Reed JC (1999). IAP family proteins - suppressors of apoptosis. Genes Dev 13:239-252.
7. Evan GI, Vousden KH (2001). Proliferation, cell cycle and apoptosis in cancer. Nature 411:342-348.
8. Fan Z, Shang BY, Lu Y, Chou JL, Mendelsohn J (1997). Reciprocal changes in p27(Kip1) and p21(Cip1) in growth inhibition mediated by blockade or overstimulation of epidermal growth factor receptors. Clin Cancer Res 3:1943-1948.
9. Fortugno P, Wall NR, Giodini A, O'Connor DS, Plescia J, Padgett KM, et al. (2002). Survivin exists in immunochemically distinct subcellular pools and is involved in spindle microtubule function. J Cell Sci 115:575-585.
10. Friedlander PL, Schantz SP, Shaha AR, Yu G, Shah JP (1998). Squamous cell carcinoma of the tongue in young patients: a matched-pair analysis. Head Neck 20:363-368.
11. Grossman D, McNiff JM, Li F, Altieri DC (1999). Expression of the apoptosis inhibitor, survivin, in nonmelanoma skin cancer and gene targeting in a keratinocyte cell line. Lab Invest 79:1121-1126.
12. Hoffman WH, Biade S, Zilfou JT, Chen J, Murphy M (2002). Transcriptional repression of the anti-apoptotic survivin gene by wild type p53. J Biol Chem 277:3247-3257.
13. Jordan RC, Bradley G, Slingerland J (1998). Reduced levels of the cell-cycle inhibitor p27Kip1 in epithelial dysplasia and carcinoma of the oral cavity. Am J Pathol 152:585-590.
14. Kudo Y, Takata T, Ogawa I, Sato S, Nikai H (1999). Expression of p53 and p21CIP1/WAF1 proteins in oral epithelial dysplasias and squamous cell carcinomas. Oncol Rep 6:539-545.
15. Kudo Y, Takata T, Ogawa I, Zhao M, Sato S, Takekoshi T, et al. (2000). Reduced expression of p27(Kip1) correlates with an early stage of cancer invasion in oral squamous cell carcinoma. Cancer Lett 151:217-222.
16. Li F, Ambrosini G, Chu EY, Plescia J, Tognin S, Marchisio PC, et al. (1998). Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 396:580-584.
17. Lo Muzio L, Staibano S, Pannone G, Mignogna MD, Mariggio A, Salvatore G, et al. (2001). Expression of the apoptosis inhibitor survivin in aggressive squamous cell carcinoma. Exp Mol Pathol 70:249-254.
18. Lu CD, Altieri DC, Tanigawa N (1998). Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas. Cancer Res 58:1808-1812.
19. Mattijssen V, Peters HM, Schalkwijk L, Manni JJ, van 't Hof-Grootenboer B, de Mulder PH, et al. (1993). E-cadherin expression in head and neck squamous-cell carcinoma is associated with clinical outcome. Int J Cancer 55:580-585.
20. McAlinden RL, Maxwell P, Napier S, Hamilton P, Cowan CG, Lundy FT, et al. (2000). Bcl-2 expression in sequential biopsies of potentially malignant oral mucosal lesions assessed by immunocytochemistry. Oral Dis 6:318-326.
21. Mineta H, Miura K, Suzuki I, Takebayashi S, Amano H, Araki K, et al. (1999). Low p27 expression correlates with poor prognosis for patients with oral tongue squamous cell carcinoma. Cancer 85:1011-1017.
22. Mirza A, McGuirk M, Hockenberry TN, Wu Q, Ashar H, Black S, et al. (2002). Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway. Oncogene 21:2613-2622.
23. Pindborg JJ, Reichart PA, Smith CJ, van der Waal I (1997). Histological typing of cancer and precancer of the oral mucosa. Berlin: Springer.
24. Saito T, Nakajima T, Mogi K (1999). Immunohistochemical analysis of cell cycle-associated proteins p16, pRb, p53, p27 and Ki-67 in oral cancer and precancer with special reference to verrucous carcinomas. J Oral Pathol Med 28:226-232.
25. Salvesen GS, Duckett CS (2002). IAP proteins: blocking the road to death's door. Nat Rev Mol Cell Biol 3:401-410.
26. Schepman K, der Meij E, Smeele L, der Waal I (1999). Concomitant leukoplakia in patients with oral squamous cell carcinoma. Oral Dis 5:206-209.
27. Schildt EB, Nylander K, Eriksson M, Hardell L, Magnusson A, Roos G (2003). Expression of p53, PCNA, Ki-67 and bcl-2 in relation to risk factors in oral cancer - a molecular epidemiological study. Int J Oncol 22:861-868.
28. Scully C (1995). Oral precancer: preventive and medical approaches to management. Eur J Cancer B Oral Oncol 31(B):16-26.
29. Singh BB, Chandler FW Jr, Whitaker SB, Forbes-Nelson AE (1998). Immunohistochemical evaluation of bcl-2 oncoprotein in oral dysplasia and carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 85:692-698.
30. Zhou M, Gu L, Li F, Zhu Y, Woods WG, Findley HW (2002). DNA damage induces a novel p53-survivin signaling pathway regulating cell cycle and apoptosis in acute lymphoblastic leukemia cells. J Pharmacol Exp Ther 303:124-131.